MEDISCA Australia | Nutraceutical Therapy – A Functional and Integrative Approach | 10-11 July 2023
MEDISCA Australia
Nutraceutical Therapy – A Functional and Integrative Approach
10-11 July 2023 | Live Seminar
ACTIVITY DESCRIPTION
Nutraceutical therapy has been shown to contribute significantly to an individual’s overall health. Indeed, the use of nutraceuticals has been associated with positive outcomes across nearly all physiological systems, including immunology, neurology, mental health, orthopaedics, cosmetics, obstetrics, cancer and other pathologies, among much more. With advances in molecular biology and genetics, nutrient and health relations are beginning to be teased apart. Over the past few decades, an abundance of scientific data has emerged highlighting the important and essential role nutrients play in cellular and epigenetic signalling. Understanding the mechanisms of nutrient actions will allow healthcare providers to better assess nutrient deficiencies and appropriately target nutraceutical interventions.
In this live event course, participants will gain a comprehensive understanding of nutrient signalling with particular emphasis on nutrient roles in methylation and epigenetic processes. Connections between methylation pathways, nutrient involvement, and the presence/absence of pathology will be made. After acquiring a foundational knowledge on nutrient molecular mechanisms, participants will assess detailed patient data, including prior medical history, familial history, differential diagnoses, lifestyle behaviours, signs and symptoms, biological assays, among much more. Participants will be encouraged to take a functional and integrative approach towards nutraceutical medicine that involves addressing the underlying cause of disease. In doing so, participants will learn about the need for customised nutraceutical therapeutics.
This program will allow pharmacists and healthcare providers with the unique opportunity to collaborate to produce patient-centred treatment regimens tailored to the individual. In attending the program, participants will leave with the confidence and knowledge required for effective and optimal nutraceutical medicine.
Intended audience
Physicians, pharmacists and healthcare providers engaged in nutraceutical treatment options for methylation disorders.
Learning Objectives
- Recognise and understand regulations surrounding nutraceutical therapy.
- Understand the bases and technologies which are appropriate when compounding nutraceutical medications.
- Develop a comprehensive understanding of epigenetic and methylation processes.
- Evaluate scientific data and findings on the relation between aberrant methylation and common pathologies.
- Recognise the important and necessary role of nutrients in methylation pathways.
- Identify the individualised nature of nutrient and methylation profiles and the need for personalised nutraceutical therapy.
- Examine and develop an understanding of treatment options for methylation disorders including Attention Deficit Hyperactivity Disorder (ADHD), Alzheimer’s Disease, Anxiety, Depression and Heavy Metal Toxicity.
- Analyse comprehensive patient cases, including prior medical history, familial history, differential diagnoses, lifestyle behaviours, signs and symptoms, laboratory test results, current and past pharmacotherapeutic and supplementation treatments.
- Develop alternative and customised therapeutic regimens tailored to patient-specific needs.
Live In-Person Seminar (1 day x 8 hours) that allows you to collaborate and network with fellow healthcare providers through interactive group discussions and case studies. Bonus In-Person Workshop* (3 hours on the following day) for compounding pharmacists and compounding technicians.
*Bonus Workshop is not apart of the accredited CPD activity.
DAY 1 | 8:00am - 5:00pm |
DAY 2 | 8:00am - 12:00pm |
Nutraceutical Therapy – A Functional and Integrative Approach
Schedule - Day 1 Seminar
Morning Session (08:30 -10:15)
Introduction
Epigenetics
Methylation
Pharmacoepigenomics
Investigations
MTHFR
COMT
Methylation and Mood Disorders
Q and A
Morning Tea (10:15 – 10:30)
Mid-Morning Session (10:30 – 13:00)
Walsh
SAMe Responsive
Folate Responsive
Bipolar
Fertility, Pregnancy and Methylation
Q and A
Competency Assessment (15 mins)
Lunch (13:00 -14:00)
Mid-Afternoon Session (14:00 – 15:15)
Methylation and Autism
Methylation and ADHD
Methylation and CVD
Q and A
Afternoon Tea (15:15 – 15:30)
Afternoon Session (15:30 – 17:30)
Methylation and Heavy Metals
Metallothinonin
Methylation Alzheimer’s
Q and A
Competency Assessment (15 mins)
Close
Schedule - Day 2 Seminar
- Calculations
- Regulations
- Product Innovation
Travel information
Please call the hotel and quote the MEDISCA Seminar to book with the event rate (03) 9322 8000
https://www.radissonhotels.com/en-us/hotels/radisson-melbourne-flagstaff-gardens
LILY TOMAS, MD, MBBS (UNSW), RACGP | Dr. Lily Thomas is an Integrative Medical Doctor practicing on the Sapphire Coast in NSW, Australia with over 20 years’ experience in treating all aspects of Health. Dr. Thomas is a Fellow of the Australasian College of Nutrition and Environmental Medicine (ACNEM) and Past President of the Australian Integrative Medical Association (AIMA). Dr. Tomas was the founding Editor of Advances in Integrative Medicine, Elsevier. Dr. Thomas has also had the pleasure of lecturing at many renowned organizations and associations, including AIMA, ACNEM, Australasian Academy of Anti-Aging Medicine (A5M), Australian Lifestyle Medicine Association (ALMA), BioBalance Health Australia, MINDD Foundation, Australian Acupuncture & Chinese Medicine Association (AACMA), University of Western Sydney- Medicine Faculty, Royal Australian College of General Practitioners (RACGP), and the McGrath Foundation- Breast Cancer. |
SARA MONFARED, BPHARM, BSC (PCOL), GRAD DIP (PCOL), MPS | Compounding Services Pharmacist, MEDISCA Australia |
ALEXIS RODRIGUEZ | Sales Executive, MEDISCA Australia |
*The facilitator for the CPD accredited activity is Dr Lily Tomas. Sara Monfared and Alexis Rodriguez facilitate the non-accredited additional training on the second day, which is designed for pharmacists and pharmacy technicians.
For Pharmacists:
Accreditation Number: A2305MED1-S (Seminar)
This activity has been accredited for 7.5 hrs of Group 1 CPD (or 7.5 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan which can be converted to 7.5 hrs of Group 2 CPD (or 15 CPD credits) upon successful completion of relevant assessment activities.
Pharmacist Competencies: 1.4, 1.5, 2.1, 2.2, 3.1, 3.2, 3.4, 3.5, 3.6
The 2016 Competency Standards addressed by this activity include
1.4 | Maintain and extend professional competence |
1.5 | Apply expertise in professional practice |
2.1 | Collaborate and work in partnership for the delivery of patient centred, culturally responsive care |
2.2 | Collaborate with professional colleagues |
3.1 | Develop a patient centred, culturally responsive approach to medication management |
3.2 | Implement the medication management strategy or plan |
3.4 | Compound medicines |
3.5 | Support Quality Use of Medicines |
3.6 | Promote health and well-being |
For Physicians:
This Activity may be eligible for self-directed credits.
Price
CANCELLATION AND REFUND POLICY
In the event that MEDISCA Australia cancels a course, MEDISCA Australia’s sole liability shall be course repayment. In no event shall MEDISCA Australia be responsible for any costs arising from such cancellation, including but not limited to travel and/or accommodation.In the event a Registrant cancels their enrollment in a CPD Activity, a written request must be sent to MEDISCA Australia requesting ‘Cancellation without Transfer’ to an alternate live CPD Activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. MEDISCA Australia shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to MEDISCA Australia in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, MEDISCA Australia will not issue any refunds, only transfer to an alternate live activity event date.This cancellation and refund policy is specific to courses offered in Australia. To obtain information on the cancellation and refund policy for courses offered outside of Australia, please speak to a MEDISCA Australia representative or refer to your course-specific registration page.
TRANSFER POLICY – AUSTRALIA COURSES ONLY
This transfer policy is only applicable to courses that are offered in Australia. Transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity event date. Failure to submit “Transfer Request” at least 14 days prior to original live activity event date will default to “Cancellation and Refund Policy”. Transfer policy can only apply one (1) time. Transfer to a new live event date must be within current calendar year. Failure to attend the new live activity event will lead to no refund and will no longer be transferable. Confirmation of new activity date is subject to the approval by MEDISCA Australia based on the number of available seats within the selected live activity event.